±¦ÔËÀ³¹Ù·½ÓéÀÖÍøÕ¾

English

±¦ÔËÀ³¹Ù·½ÓéÀÖÍøÕ¾ÉúÎïѪ˨ËÄÏî | ¾«×¼·¢Á¦£¬»¤º½Ôвú¸¾³öÄýѪ¼ì²â

Ðû²¼ÓÚ£º2025-01-06

ÎÄÕÂȪԴ£º[ÖÐÎÄ]±¦ÔËÀ³¹Ù·½ÓéÀÖÍøÕ¾ÉúÎï



01

Ôвú¸¾ÑªË¨ÐÔ¼²²¡ÏÖ×´


ƾ֤WHOÆÊÎö£¬ÔÚÅ¹ú¼ÒÓëÉú³¤Öйú¼Ò£¬Ôвú¸¾ËÀÓÉÓÚѪ˨˨ÈûÐÔ¼²²¡µÄÕ¼3.1%~13.8%¡£Ôи¾×÷ΪÌØÊâÈËȺ£¬ÓÉÓÚÈÑÉïÆÚ´ÆÔм¤ËصÄÔöÌí£¬»úÌåÔ­ÓÐÄýѪºÍÏËÈÜϵͳµÄƽºâ±»Í»ÆÆ£¬Ôö½øÁËÈÑÉïÆÚѪ˨ǰ״̬£¨Ò×˨֢£©ºÍѪ˨ÐÔ²¢·¢Ö¢µÄ±¬·¢¡£ÄýѪºÍÏËÈÜϵͳÒì³£¿ÉÄܵ¼ÖÂÔи¾±¬·¢¾²ÂöѪ˨˨ÈûÖ¢£¨VTE£©µÄΣº¦±ÈÒ»Ñùƽ³£ÈËȺ¸ß50±¶£¬VTEÒѳÉΪÌìϹæÄ£ÄÚÔС¢²ú¸¾µÄµÚ¶þËÀÒòÉõÖÁÉÙÊýÅ¹ú¼ÒµÄµÚÒ»ËÀÒò¡£Éî¾²ÂöѪ˨(DVT)²»ÊµÊ±ÕïÖΣ¬15%¡«24%Éú³¤Îª·Î˨Èû(PE)£»66%µÄÔвú¸¾ÔÚPE±¬·¢µÄ30minÄÚéæÃü¡£



02

Ôвú¸¾³öÄýѪ¼ì²âÏÖ×´


³öÄýѪ¼ì²âÊÇÆÀ¹ÀÈÑÉïÆÚºÍÁÙÅèÆÚ¸¾Å®ÑªÒºÄý¹Ì¹¦Ð§×´Ì¬µÄÖ÷ÒªÊֶΣ¬ÕâÓÐÖúÓÚʶ±ðºÍ¹ÜÀíDZÔÚµÄÄýѪÒì³££¬ÓÈÆäÊÇÔÚ¸ßΣº¦ÈÑÉï¡¢²úºó³öѪÒÔ¼°ÃÖÉ¢ÐÔѪ¹ÜÄÚÄýѪ(DIC)µÈ²¢·¢Ö¢µÄÇéÐÎÏ¡£½üÄêÑо¿Ï£Íû¿ì¡¢ÁÙ´²Ö¸µ¼ÒâÒåÇ¿µÄÐÂÐÍÄýѪ·Ö×Ó±ê¼ÇÎï°üÀ¨ÄýѪø-¿¹ÄýѪø¸´ºÏÎï(thrombin-antithrombin compex£¬TAT)¡¢ÏËÈÜø-¿¹ÏËÈÜø¸´ºÏÎï(plasmin antiplasmincomplex£¬PIC)¡¢×éÖ¯ÐÍÏËÈÜøԭ¼¤»îÎï-ÏËÈÜøԭ¼¤»îÒÖÖÆÎï-1¸´ºÏÎï(tissue plasminogen activator-plasminogen activator inhibitor-l complex£¬t-PAIC)¼°ÑªË¨µ÷ÀíÂÑ°×(thrombomodulin£¬TM)£¬¼ò³ÆÐÂѪ˨ËÄÏÔÚ²ú¿ÆVTEÔçÆÚÕï¶Ï¡¢¸´·¢ÐÔÁ÷²ú(RSA)µÈ²ú¿ÆÏà¹ØѪ˨¼²²¡ÖоßÓÐÖ÷ÒªÁÙ´²Ó¦ÓüÛÖµ¡£





±¦ÔËÀ³¹Ù·½ÓéÀÖÍøÕ¾ÉúÎïÐÂѪ˨ËÄÏîÒÑÈ¡µÃ×¢²áÖ¤£¬ÎªÔвú¸¾³öÄýѪ¼ì²âÌṩǿÁ¦Ö§³Ö£¡



03

ÐÂѪ˨ËÄÏîÖúÁ¦Ôвú¸¾VTEÔçÕïÔçÖÎ


ΪÁ˽µµÍ²úÇ°ºÍ²úºó³öѪµÄΣº¦£¬²¢ÔÚÈÑÉïºÍÁÙÅèʱ´úά³ÖÌ¥Å̹¦Ð§£¬ÐÄÀí¸ßÄý״̬Åãͬ×ÅÕû¸öÈÑÉïʱ¼ä£¬È»¶øÌ«¹ýµÄ¸ßÄý״̬¼«Òײ¢·¢ÈÑÉïÆÚVTE¡£Éò„µÈÑо¿Åú×¢CapriniÆÀ·ÖÓë¾²ÂöѪ½¬TM¡¢TAT¡¢t-PAIC¡¢PICˮƽ¶ÔÆʹ¬²úÊõºóDVTÐγÉΣº¦ÓнϺõÄÕ¹Íû¼ÛÖµ£¬ÌáÐÑÁÙ´²¿Éƾ֤ÐÂѪ˨ËÄÏîˮƽÔçÆÚ½ÓÄɲ½·¥Ô¤·ÀÊõºóDVTµÄ±¬·¢¡£ÍõÓîµÈÑо¿Åú×¢TM¡¢TAT¡¢t-PAIC¡¢PICΪӰÏìÔÐÖÐÍíDVT±¬·¢µÄ×ÔÁ¦Õ¹ÍûÒò×Ó£¬ÐÂѪ˨ËÄÏîÍŽá¼ì²â¶ÔÔÐÖÐÍíÆÚÔи¾±¬·¢DVTµÄÕ¹Íû¼ÛÖµÏÔ×ÅÓÅÓÚ¸÷µ¥ÏîÖ¸±ê¼ì²â»òÁ½Á½ÍŽᣨP£¼0.05£©£¬ÌáÐÑÍŽá¼ì²â¿ÉΪÁÙ´²ÔçÆÚÕïÖÎÌṩ²Î¿¼£¬¼ûϱí¡£




04

ÐÂѪ˨ËÄÏîÖúÁ¦¸´·¢ÐÔÁ÷²ú²¡Òòɸ²é


RSAÊÇÖ¸ÓëͳһÐÔÅóÙ­Ò»Á¬±¬·¢¡Ý3´ÎµÄ×ÔÈ»Á÷²ú£¬²¢ÇÒÿ´ÎÁ÷²ú³£±¬·¢ÔÚͳһÔÐÁ䡣ѪҺ¸ßÄý״̬£¬Ò²½ÐѪ˨ǰ״̬(PTS)£¬Êǵ¼ÖÂRSAµÄ³£¼ûÔµ¹ÊÔ­ÓÉ£¬PTS»áÔÚÌ¥Å̲¿Î»ÐγÉ΢Ѫ˨£¬ÒýÆðÅßÌ¥»òÌ¥¶ùȱѪȱÑõ£¬×îÖÕµ¼ÖÂÁ÷²ú¡£


ÐÂѪ˨±ê¼ÇÎï¶ÔPTSÓÐÖ÷ÒªÌáÐÑÒâÒ壬¡¶¸´·¢ÐÔÁ÷²úºÏ²¢ÑªË¨Ç°×´Ì¬ÕïÖÎÖйúר¼Ò¹²Ê¶(2021)¡·ÖÐÖ¸³ö¹ØÓÚRSAºÏ²¢PTS»¼Õß¾ÙÐÐÄýѪ¹¦Ð§µÄɸ²é£¬³ýPT¡¢APTTµÈ³£ÓÃÖ¸±êÍ⣬ÓÐÌõ¼þÕß¿É¿ªÕ¹TAT¡¢TM¡¢PICÖзÖ×Ó±ê¼ÇÎÒÔÆÀ¼Û»¼ÕßÌåÄÚÄýѪ¹¦Ð§¼°Ñª¹ÜÄÚƤ״̬£¬Èçͼ1Ëùʾ¡£¡¶¸´·¢ÐÔÁ÷²ú²¡Òò¼ì²éר¼Ò¹²Ê¶(2022)¡·Öн¨ÒéÓÐÌõ¼þÕß¿É¿ªÕ¹ÐÂѪ˨4Ïî(TM¡¢TAT¡¢t-PAIC¡¢PIC)¼ì²â¡£


ͼ1?¸´·¢ÐÔÁ÷²úPTSÆÀ¹Àɸ²éÁ÷³Ì

ȪԴ£º¡¶¸´·¢ÐÔÁ÷²úºÏ²¢ÑªË¨Ç°×´Ì¬ÕïÖÎÖйúר¼Ò¹²Ê¶(2021)¡·



05

ÐÂѪ˨ËÄÏîÈÑÉïÆڲο¼Çø¼ä


ÏÖÔÚ¾ø´ó´ó¶¼ÊµÑéÊÒ¸ø³öµÄÄýѪָ±ê²Î¿¼¹æÄ£¶¼ÊÇ·ÇÔÐÆÚºÍͨË×ÈËȺ£¬¶øÈÑÉïÆÚÔи¾µÄѪҺÊÇ´¦ÓÚÐÄÀíÐԵĸßÄý״̬£¬¹ÊÔи¾²»¿É²ÎÕÕ·ÇÈÑÉïÈËȺÄýѪָ±êµÄ²Î¿¼Çø¼ä£¬ÔÚ½«ÑªË¨ËÄÏîÖ¸±êÆÕ±éÓÃÓÚÈÑÉïʱ´úÓëѪ˨ÐÔ¼²²¡µÄÁÙ´²ÆÀ¹À֮ǰ£¬ÓÐÐëҪΪ¿µ½¡Ôвú¸¾½¨Éè²Î¿¼Çø¼ä¡£±±¾©´óѧµÚÈýÒ½ÔºÕÅæµ¾²µÈÏÈÉúÔÚ¡¶THE JOURNAL OF Obstetrics ancGynaecology Research¡·½ÒÏþµÄѧÊõÂÛÎĶÔÖйúÔи¾ÈÑÉïÆÚTAT¡¢TM¡¢t-PAIC¡¢PICµÄת±ä¼°¿µ½¡Ôвú¸¾ÈÑÉïÆÚÌض¨²Î¿¼¹æÄ£¾ÙÐÐÁËÑо¿¡£Ñо¿ÄÉÈ뻪±±µØÇø190Àý¿µ½¡Ôвú¸¾£¬½ÓÄÉ»¯Ñ§·¢¹â·¨¼ì²âTAT¡¢TM¡¢t-PAICºÍPICˮƽ£¬ÔÚ2.5%ºÍ97.5%µÄÂþÑܹæÄ£½¨ÉèÁËÈÑÉïÆÚÌض¨²Î¿¼Çø¼ä£¨Ð§¹û¼û±í2£©¡£×îÖÕÑо¿Åú×¢£¬TAT¡¢TM¡¢t-PAICµÄˮƽ´ÓÔÐÔçÆÚ(ÈÑÉï5-12ÖÜ)µ½ÔÐÍíÆÚ(ÈÑÉï28-40ÖÜ)ÏÔ×ÅÔöÌí£¬¶øPICµÄˮƽ²¢Ã»ÓÐËæ×ÅÔÐÖܵÄÔöÌí¶ø±¬·¢ÏÔÖøת±ä¡£



×ÛÉÏËùÊö£¬ÐÂѪ˨ËÄÏî±ê¼ÇÎïÏà±È¹Å°åÄýѪËÄÏî¡¢D-Dimer¡¢FDP¸üÔç¡¢¸üÌØÒ죬ÔÚѪ˨×îÏÈÐγɽ׶ξÍÓÐÏÔ×Åת±ä£¬ÔÚÔÐÆÚ¡¢²úÇ°¡¢²úºó¶¯Ì¬¼ì²âͨÀýÄýѪÏîÄ¿µÄͬʱ£¬ÖÜÆÚÐԺϲ¢¼à²âTAT¡¢TM¡¢t-PAIC¡¢PICˮƽÄܹ»ÈÃÁÙ´²Ò½Éú¸ü׼ȷµØÅжÏÔвú¸¾ÊÇ·ñ±£´æVTEµÄΣº¦£¬ÊµÏÖ²ú¿ÆVTEÔçÆÚÕï¶Ï¡¢RSAµÈ²ú¿ÆÏà¹ØѪ˨¼²²¡µÄÔçÆÚʶ±ðºÍ¸ÉÔ¤£¬´Ó¶øµÖ´ï¸üºÃµÄÔ¤·À±£½¡Ð§¹û¡£





±¦ÔËÀ³¹Ù·½ÓéÀÖÍøվѪ˨ËÄÏî²úÆ·ÏÈÈÝ


? ÒªÁìѧ£º´Å΢Á£»¯Ñ§·¢¹â·¨

??Ñù±¾ÀàÐÍ£ºèÛéÚËáÄÆѪ½¬

??У׼ÖÊ¿Ø£ºËæºÐÔùÓè

??ÊÊÓûúÐÍ£ºÈ«ÐÂÈý¿îÈ«×Ô¶¯»¯Ñ§·¢¹âÒÇÆ÷¡£¾ßÓÐÕ¼µØС£¬²âÊÔËÙÂʿ죬ÎÞаÐԸߵÈÓÅÊÆ£¬¿ÉÒÔÖª×ã¶àÖÖÖն˿ͻ§ÐèÇó¡£



²Î¿¼ÎÄÏ×

[1]?Say L, Chou D, Gemmill A,et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014 Jun;2(6):e323-33.

[2]?Bourjeily G, Paidas M, Khalil H,et al.Pulmonary embolism in pregnancy. Lancet. 2010 Feb 6; 375(9713): 500-12.

[3]?Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy [J]. Blood Adv, 2018, 2(22): 3317-3359.

[4]?ÍõÓî, ËïÇïèª, ÕÅö©ö©µÈ. TAT¡¢PIC¡¢TM¡¢tPAI-CÕ¹ÍûÔÐÖÐÍíÆÚÔи¾Éî¾²ÂöѪ˨¼ÛÖµ[J]. ÖйúÍýÏëÉúÓýѧÔÓÖ¾, 2021, 29(01): 79- 83+211.

[5]?Éò„Â, ²Ì¿¡½Ü, ÖìÝíö©. ¾²ÂöѪ½¬ÖÐѪ˨µ÷ÀíÂѰס¢ÄýѪø-¿¹Äý Ѫø¸´ºÏÎï¡¢×éÖ¯ÐÍÏËÈÜøԭ¼¤»î¼Á-ÒÖÖÆÎ︴ºÏÎï¡¢ÏËÈÜø-¿¹ ÏËÈÜø¸´ºÏÎïˮƽÍŽáCapriniÆÀ·ÖÕ¹ÍûÆʹ¬²úÊõºóÏÂÖ«Éî¾²ÂöѪ˨ÐγÉΣº¦[J]. ÖйúÐÔ¿Æѧ, 2023, 32(03): 75-79.

[6]?¸´·¢ÐÔÁ÷²úºÏ²¢ÑªË¨Ç°×´Ì¬ÕïÖÎÖйúר¼Ò¹²Ê¶.ÖлªÉúÖ³Óë±ÜÔÐÔÓÖ¾ 2021 Äê10 ÔÂµÚ 41 ¾íµÚ 10 ÆÚ 0861-0875.

[7]?Trimester-specific reference intervals of TAT, TM, tPAI-C and PIC for healthy Chinese pregnant women.J. Obstet. Gynaecol. Res. Vol. 47, No. 1: 368¨C374, January 2021

ÉÏÏ»¬¶¯Éó²éÍêÕû²Î¿¼ÎÄÏ×



END

ÎÄÕÂȪԴ£º±¦ÔËÀ³¹Ù·½ÓéÀÖÍøÕ¾ÉúÎï

Ôð±à£ºEcho

У¶Ô£ºPretty¡¢Miss Jia


 
ÍøÕ¾µØͼ